▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collection 10.03125
▁and 1.6943359375
▁analysis 0.6806640625
▁of 0.04559326171875
▁statistical 4.203125
▁data 0.120361328125
. 0.89599609375
▁Part 4.94921875
icip 0.06683349609375
ants 0.04595947265625
▁were 0.70361328125
▁rec 3.2578125
ru 0.0010690689086914062
ited 4.839897155761719e-05
▁for 4.05078125
▁six 7.5546875
▁months 0.52197265625
▁at 3.771484375
▁two 2.498046875
▁major 5.4453125
▁pain 3.078125
▁relief 5.24609375
▁cent 1.5498046875
ers 0.07904052734375
▁in 0.70947265625
▁Israel 4.3203125
. 0.41552734375
▁The 1.1923828125
▁research 2.166015625
ers 1.505859375
▁used 2.705078125
▁The 8.0625
▁De 4.21484375
pression 0.01334381103515625
▁Module 10.1171875
▁of 0.95947265625
▁the 0.32568359375
▁Pat 2.287109375
ient 0.007503509521484375
▁Health 0.08447265625
▁Question 0.013946533203125
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73095703125
▁General 1.6826171875
ized 0.69140625
▁An 0.016021728515625
x 0.0001443624496459961
iety 0.002651214599609375
▁Dis 0.5146484375
order 0.034881591796875
▁Sc 1.205078125
ale 0.068359375
▁to 1.7373046875
▁interview 7.06640625
▁participants 2.017578125
, 3.697265625
▁evaluate 5.56640625
▁their 0.7431640625
▁answers 6.48828125
, 0.853515625
▁and 0.1422119140625
▁conduct 4.4453125
▁the 2.296875
▁study 2.2421875
. 0.224609375
▁To 5.09375
▁specifically 9.8828125
▁evaluate 2.580078125
▁and 4.35546875
▁compare 0.9423828125
▁the 0.338134765625
▁prob 11.1328125
abilities 0.1806640625
▁of 0.1295166015625
▁de 0.82421875
pression 0.03790283203125
▁or 4.5859375
▁anx 0.03558349609375
iety 0.0002944469451904297
▁among 1.7216796875
▁the 2.263671875
▁diverse 8.8984375
▁groups 1.564453125
, 1.4130859375
▁the 1.0107421875
▁study 2.673828125
▁used 1.623046875
▁multiple 4.734375
▁log 2.884765625
istic 0.03607177734375
▁regression 0.101318359375
▁analysis 0.6630859375
▁and 2.53125
▁chose 8.8984375
▁medical 7.41015625
▁mar 0.322021484375
iju 0.0015125274658203125
ana 0.00019562244415283203
▁as 0.794921875
▁the 1.083984375
▁control 2.7265625
▁group 0.5537109375
. 0.285888671875
<0x0A> 0.7548828125
The 0.96630859375
▁analysis 4.7890625
▁of 0.99609375
▁any 9.9140625
▁human 6.39453125
▁reaction 5.0234375
▁has 4.66015625
▁a 1.8046875
▁high 4.4296875
▁potential 3.50390625
▁of 1.5849609375
▁subject 5.109375
iveness 4.14453125
▁and 1.455078125
▁bias 2.369140625
, 1.8837890625
▁especially 2.34765625
▁regarding 3.93359375
▁people 4.828125
▁in 3.90625
▁severe 4.328125
▁pain 0.1947021484375
▁and 2.568359375
▁un 5.5625
stable 2.30078125
▁emot 1.033203125
ional 0.20751953125
▁condition 2.365234375
. 0.10174560546875
▁Perhaps 8.9375
▁some 4.796875
▁patients 2.396484375
▁tend 6.0546875
▁to 0.020751953125
▁ex 3.060546875
agger 0.0020427703857421875
ate 0.005695343017578125
▁their 0.76708984375
▁de 4.4921875
press 1.5107421875
ive 0.2364501953125
▁state 3.02734375
▁or 2.033203125
▁vice 7.515625
▁vers 0.021575927734375
a 8.618831634521484e-05
, 1.1494140625
▁de 6.99609375
- 5.4375
emph 1.013671875
as 0.00511932373046875
ize 0.2174072265625
▁serious 7.00390625
▁difficulties 6.34765625
. 0.9208984375
▁Because 5.88671875
▁the 2.130859375
▁survey 6.2109375
▁responses 7.265625
▁were 0.853515625
▁thoroughly 8.734375
▁anonymous 4.28515625
, 0.39794921875
▁the 1.244140625
▁research 1.55078125
ers 0.31103515625
▁were 1.3857421875
▁unable 1.8447265625
▁to 0.003223419189453125
▁carefully 8.484375
▁analyze 1.724609375
▁each 3.74609375
▁patient 2.236328125
’ 27.296875
s 0.54150390625
▁reaction 3.53125
▁and 2.494140625
▁compare 3.712890625
▁it 0.8935546875
▁to 1.0390625
▁the 0.65478515625
▁actual 5.64453125
▁states 7.359375
▁of 0.6357421875
▁condition 7.8125
. 0.358642578125
▁More 6.8046875
▁accurate 3.591796875
▁answers 4.515625
▁could 2.41015625
▁be 0.9111328125
▁obtained 0.9736328125
▁by 1.2431640625
▁professional 7.46484375
▁psych 1.923828125
olog 0.4091796875
ists 0.0014514923095703125
▁via 7.99609375
▁personal 4.21484375
▁communication 4.82421875
▁and 2.033203125
▁behavior 7.07421875
al 0.36279296875
▁analysis 2.275390625
. 0.2430419921875
▁However 2.81640625
, 0.003040313720703125
▁this 2.16015625
▁method 3.05859375
▁of 2.265625
▁research 2.26953125
▁is 1.1826171875
▁way 8.2265625
▁more 1.9423828125
▁resource 6.37109375
- 0.43017578125
int 0.53271484375
ensive 0.00830841064453125
▁and 0.68017578125
▁energy 8.921875
- 0.1422119140625
consum 0.305908203125
ing 0.002044677734375
. 0.74755859375
<0x0A> 0.84619140625
This 3.294921875
▁type 5.14453125
▁of 0.004787445068359375
▁study 1.423828125
▁is 1.2861328125
▁the 3.697265625
▁most 1.3505859375
▁reve 8.109375
aling 0.0007205009460449219
▁and 0.849609375
▁inclus 6.5625
ive 0.003265380859375
, 2.029296875
▁as 2.345703125
▁it 0.462890625
▁contains 5.140625
▁direct 5.765625
▁responses 3.123046875
▁from 0.86328125
▁a 3.857421875
▁large 1.0908203125
▁number 0.51904296875
▁of 0.0031948089599609375
▁participants 1.7412109375
. 0.57373046875
▁All 4.5
▁tools 9.7578125
▁in 4.67578125
▁the 0.65869140625
▁form 3.60546875
▁of 0.035858154296875
▁question 1.63671875
na 0.043609619140625
ires 0.00018393993377685547
▁and 1.765625
▁scales 3.42578125
▁have 3.498046875
▁already 4.1640625
▁been 0.1968994140625
▁used 2.107421875
▁and 1.97265625
▁proved 4.078125
▁their 1.8564453125
▁effic 3.798828125
acy 0.0001569986343383789
▁for 3.6171875
▁collect 4.87890625
ing 0.0235595703125
▁analyt 8.0859375
ical 0.271240234375
▁data 0.253662109375
. 0.40478515625
▁It 3.548828125
▁helps 4.73828125
▁to 0.95947265625
▁system 6.76171875
at 1.51171875
ize 0.00861358642578125
▁and 1.484375
▁class 4.21875
ify 0.0023632049560546875
▁distinct 8.9375
▁kinds 6.58984375
▁of 0.0227203369140625
▁information 4.31640625
▁for 4.11328125
▁subsequent 4.23046875
▁un 7.54296875
comp 5.26953125
licated 0.0601806640625
▁services 12.5234375
. 0.81640625
▁Thus 4.53515625
, 0.037384033203125
▁research 4.54296875
ers 0.388427734375
▁can 1.650390625
▁compare 3.830078125
▁the 0.96240234375
▁effects 2.82421875
▁of 0.09344482421875
▁medic 4.60546875
ations 0.90966796875
▁on 1.9521484375
▁patients 2.03125
▁of 4.23828125
▁diverse 4.0078125
▁age 2.87109375
▁groups 0.85693359375
, 0.7900390625
▁background 4.8203125
s 0.302001953125
, 0.07403564453125
▁physical 5.1171875
▁conditions 1.3212890625
, 0.1063232421875
▁emot 3.9453125
ional 0.047119140625
▁states 1.427734375
, 0.13818359375
▁and 0.478271484375
▁so 3.16796875
▁on 0.2919921875
. 0.068115234375
<0x0A> 0.75244140625
Part 5.62109375
icip 0.1038818359375
ants 0.11712646484375
▁were 1.0810546875
▁rec 1.3134765625
ru 0.0012359619140625
ited 0.00012242794036865234
▁for 1.056640625
▁six 1.1083984375
▁months 0.0188751220703125
▁at 0.435791015625
▁two 0.115966796875
▁major 0.384521484375
▁pain 0.0384521484375
▁relief 0.03155517578125
▁cent 0.039031982421875
ers 0.004207611083984375
▁in 0.06982421875
▁Israel 0.036834716796875
. 0.1649169921875
▁All 3.548828125
▁patients 1.541015625
▁experienced 5.5703125
▁chron 1.8564453125
ic 0.002471923828125
▁pain 0.08367919921875
▁for 3.59765625
▁at 0.71240234375
▁least 0.000946044921875
▁ 1.1298828125
3 1.44140625
▁months 0.2352294921875
. 1.0302734375
▁The 1.4697265625
▁study 1.9560546875
▁included 2.248046875
▁ 1.1162109375
8 2.900390625
9 2.76953125
0 3.5078125
▁participants 1.505859375
, 1.2578125
▁of 1.7177734375
▁which 0.395751953125
▁ 0.14892578125
4 1.5869140625
7 2.474609375
4 2.740234375
▁( 2.1953125
5 0.0875244140625
9 11.1484375
%) 0.97900390625
▁were 0.46240234375
▁treated 4.6484375
▁sole 6.84375
ly 0.00010836124420166016
▁with 0.461669921875
▁op 0.8056640625
io 0.411376953125
ids 0.18896484375
, 1.1591796875
▁ 0.56982421875
3 1.05859375
2 2.087890625
9 2.546875
▁( 0.041046142578125
4 1.126953125
1 1.236328125
%) 0.1285400390625
▁were 1.310546875
▁treated 0.5673828125
▁with 0.1845703125
▁MM 0.80908203125
, 0.272216796875
▁and 0.1572265625
▁ 0.1429443359375
7 3.208984375
7 2.40625
▁( 0.158447265625
8 3.818359375
. 1.1591796875
6 3.1328125
%) 0.054931640625
▁acquired 9.6640625
▁both 1.16796875
▁( 6.9765625
Fe 10.171875
ing 2.84765625
old 0.0189666748046875
▁et 1.4501953125
▁al 0.0170745849609375
., 0.294921875
▁ 0.00868988037109375
2 0.160888671875
0 0.0003020763397216797
1 0.392578125
7 2.052734375
). 0.131103515625
▁The 1.41796875
▁remaining 6.9921875
▁ten 8.0390625
▁participants 1.3994140625
▁who 5.6875
▁did 1.4658203125
▁not 0.006011962890625
▁receive 1.896484375
▁ph 3.099609375
arma 0.0599365234375
ce 0.001285552978515625
ut 1.430511474609375e-05
ical 0.0033435821533203125
▁op 1.0048828125
io 0.0811767578125
ids 0.0224609375
▁and 1.6591796875
▁medical 2.404296875
▁mar 0.04315185546875
iju 0.00376129150390625
ana 5.9723854064941406e-05
▁were 1.265625
▁with 6.02734375
dra 0.134765625
wn 9.584426879882812e-05
▁from 0.253173828125
▁the 0.10736083984375
▁analysis 4.51953125
▁in 4.83203125
▁the 1.162109375
▁research 4.359375
. 0.736328125
▁Therefore 4.96484375
, 0.0083160400390625
▁it 3.935546875
▁is 1.0908203125
▁not 2.927734375
▁possible 0.64990234375
▁to 0.020721435546875
▁compreh 6.625
ens 0.046661376953125
ively 0.00830841064453125
▁compare 1.9189453125
▁patients 4.72265625
▁taking 4.3046875
▁medic 3.818359375
ations 0.438232421875
▁with 0.99755859375
▁those 1.26953125
▁who 1.1455078125
▁do 1.640625
▁not 0.007415771484375
. 0.84130859375
<0x0A> 0.64892578125
The 1.0537109375
▁study 1.6083984375
▁conducted 4.7421875
▁a 2.04296875
▁correlation 6.1328125
▁type 7.3828125
▁of 0.477783203125
▁research 1.96875
▁with 2.830078125
▁variable 7.8828125
▁measures 4.63671875
. 1.2265625
▁It 2.234375
▁evaluated 4.453125
▁the 0.58935546875
▁inter 6.48828125
dep 3.666015625
end 0.0005602836608886719
ence 0.010650634765625
▁of 0.5966796875
▁various 3.953125
▁factors 1.5400390625
▁that 2.779296875
▁affected 4.23046875
▁the 0.5966796875
▁physical 6.8828125
▁and 0.986328125
▁emot 0.427978515625
ional 0.00038123130798339844
▁condition 0.8505859375
▁of 0.1129150390625
▁patients 0.611328125
▁experien 4.04296875
cing 1.430511474609375e-05
▁chron 0.6025390625
ic 0.0004448890686035156
▁pain 0.0250701904296875
. 0.2318115234375
▁For 3.74609375
▁example 1.009765625
, 0.01511383056640625
▁the 1.2138671875
▁survey 5.09375
▁showed 3.599609375
▁that 0.395751953125
▁the 1.7373046875
▁ratio 6.96484375
▁of 0.11981201171875
▁female 4.4296875
▁patients 0.78515625
▁was 1.8662109375
▁remark 9.578125
ably 0.00047326087951660156
▁higher 0.52880859375
▁in 2.74609375
▁the 0.93798828125
▁op 4.55859375
i 4.19140625
ates 0.0797119140625
▁group 0.26025390625
▁compared 2.75390625
▁to 0.11956787109375
▁the 0.5322265625
▁MM 0.485107421875
▁group 0.266357421875
. 0.485107421875
▁In 3.00390625
▁turn 4.03125
, 0.00274658203125
▁people 6.0078125
▁on 5.44921875
▁op 1.419921875
i 0.432373046875
ates 0.003124237060546875
▁were 1.0537109375
▁more 1.0205078125
▁likely 0.380615234375
▁to 0.05975341796875
▁report 3.134765625
▁major 6.00390625
▁de 0.407470703125
press 1.2392578125
ive 0.005077362060546875
▁dis 0.53125
orders 1.302734375
. 1.7861328125
<0x0A> 2.37890625
The 1.0966796875
▁question 5.74609375
na 1.51171875
ires 9.500980377197266e-05
▁used 2.091796875
▁different 8.3203125
▁variable 8.953125
▁measures 0.8125
▁to 1.3828125
▁collect 2.3125
▁information 1.8564453125
. 1.53515625
▁For 2.015625
▁example 0.21142578125
, 0.00807952880859375
▁it 4.0546875
▁included 2.455078125
▁compreh 8.6484375
ensive 0.02667236328125
▁so 7.02734375
cio 0.01904296875
- 0.39306640625
dem 0.07965087890625
ographic 0.03900146484375
▁data 1.044921875
: 4.8671875
▁gender 1.5498046875
, 0.09027099609375
▁age 0.2017822265625
, 0.0875244140625
▁country 4.25
, 1.5439453125
▁type 4.2890625
▁of 0.056304931640625
▁residence 3.890625
▁( 3.353515625
urban 2.095703125
/ 2.90625
r 0.06414794921875
ural 0.0004911422729492188
), 0.2330322265625
▁years 5.765625
▁of 0.1734619140625
▁education 0.693359375
, 0.1494140625
▁and 1.8515625
▁employ 3.517578125
ment 0.003986358642578125
▁status 0.444091796875
. 0.1768798828125
▁Pat 3.994140625
ients 0.09814453125
▁were 1.1591796875
▁also 0.873046875
▁asked 0.609375
▁about 1.1240234375
▁their 0.60546875
▁medical 2.76171875
▁history 0.40478515625
▁over 8.75
▁the 0.154296875
▁years 4.01171875
▁and 1.7978515625
▁the 1.857421875
▁current 3.38671875
▁presence 5.75390625
▁of 0.053802490234375
▁any 2.62109375
▁severe 4.578125
▁dise 1.474609375
ases 6.759166717529297e-05
▁such 4.26953125
▁as 0.004062652587890625
▁heart 2.42578125
▁failure 2.029296875
, 0.1929931640625
▁di 1.828125
ab 0.0017452239990234375
etes 0.00411224365234375
, 0.12371826171875
▁ar 3.80859375
th 0.129150390625
rit 0.031951904296875
is 0.0119476318359375
, 0.0416259765625
▁and 1.5712890625
▁so 0.83447265625
▁on 0.033203125
. 0.050628662109375
▁The 1.8935546875
▁third 7.17578125
▁measure 4.02734375
▁of 2.173828125
▁the 1.009765625
▁question 2.71875
naire 0.1727294921875
▁was 1.005859375
▁indicated 9.8203125
▁by 0.615234375
▁information 6.36328125
▁on 1.564453125
▁any 5.26953125
▁twelve 13.625
- 1.2666015625
month 0.35302734375
▁and 5.79296875
▁lifetime 3.203125
▁drug 4.5234375
▁and 3.4765625
▁alco 0.07452392578125
hol 7.343292236328125e-05
▁consumption 2.53515625
. 0.465576171875
▁In 3.470703125
▁addition 0.794921875
, 0.1268310546875
▁the 1.1708984375
▁record 7.85546875
▁included 1.7392578125
▁a 2.498046875
▁pain 6.44921875
▁measurement 4.25
▁scale 1.048828125
▁from 3.65234375
▁ 0.455810546875
0 0.4306640625
▁to 0.41259765625
▁ 0.00677490234375
1 0.08441162109375
0 0.07684326171875
▁to 4.5390625
▁evaluate 1.5966796875
▁dis 5.828125
com 0.2249755859375
fort 0.001094818115234375
▁feelings 7.41796875
▁during 3.318359375
▁the 0.927734375
▁last 1.4208984375
▁month 1.5986328125
. 0.290283203125
<0x0A> 1.19921875
One 5.71484375
▁of 0.65576171875
▁the 0.017333984375
▁major 2.69921875
▁limitations 2.541015625
▁is 3.4609375
▁the 0.444091796875
▁ins 5.0859375
u 0.01517486572265625
fficient 0.10491943359375
ly 4.95703125
▁high 3.09375
▁response 2.8984375
▁rate 0.0887451171875
, 2.46484375
▁ 4.4921875
5 1.8525390625
7 2.388671875
% 1.2783203125
▁instead 7.37890625
▁of 0.005702972412109375
▁ 0.9189453125
7 1.5908203125
0 1.53515625
% 1.0830078125
▁( 1.697265625
Fe 0.72021484375
ing 0.005077362060546875
old 0.0002467632293701172
▁et 0.0266571044921875
▁al 0.0014066696166992188
., 0.00719451904296875
▁ 0.0014352798461914062
2 0.0005726814270019531
0 3.361701965332031e-05
1 0.0017156600952148438
7 0.012298583984375
). 0.04150390625
▁It 2.76953125
▁can 3.216796875
▁be 0.384521484375
▁fairly 8.6171875
▁explained 0.8779296875
▁by 0.1412353515625
▁the 0.3017578125
▁weak 8.5234375
▁focus 7.1484375
▁of 0.462890625
▁respond 6.765625
ents 0.11248779296875
▁who 3.69921875
▁have 3.77734375
▁overcome 8.203125
▁severe 2.158203125
▁pain 0.478759765625
▁sens 9.0078125
ations 1.1298828125
▁and 1.13671875
▁de 4.10546875
press 1.9013671875
ive 0.1934814453125
▁episodes 3.62109375
. 0.638671875
▁It 3.416015625
▁is 0.82568359375
▁not 2.595703125
▁clear 4.21875
▁how 1.7177734375
▁to 3.546875
▁use 5.578125
▁these 3.146484375
▁statistics 3.484375
, 2.33203125
▁as 1.3115234375
▁they 1.4658203125
▁still 6.45703125
▁may 4.484375
▁be 1.3125
▁relevant 4.6484375
▁for 1.333984375
▁the 1.7353515625
▁overall 4.01171875
▁analysis 2.724609375
. 0.89013671875
<0x0A> 1.1630859375
Am 6.82421875
ong 0.02093505859375
▁all 2.6328125
▁participants 2.248046875
▁in 3.6953125
▁the 0.2296142578125
▁study 0.40771484375
, 0.0704345703125
▁ 0.6337890625
4 1.8525390625
2 2.66015625
. 1.408203125
2 2.328125
% 0.1318359375
▁suffered 4.60546875
▁from 0.1387939453125
▁de 1.4375
pression 0.2117919921875
, 1.1865234375
▁and 1.9326171875
▁ 0.16748046875
3 1.6552734375
7 2.177734375
% 2.560546875
▁experienced 2.439453125
▁excess 7.734375
ive 0.07513427734375
▁anx 0.23388671875
iety 0.0017223358154296875
. 0.44921875
▁The 1.484375
▁pl 11.1953125
ur 0.9130859375
ality 0.0001322031021118164
▁of 0.2259521484375
▁de 3.478515625
press 1.1796875
ive 0.0253143310546875
▁dis 2.044921875
orders 0.03948974609375
▁among 3.791015625
▁patients 1.1591796875
▁in 3.73046875
▁the 0.51171875
▁op 1.71875
i 1.1171875
ates 0.003528594970703125
, 7.19921875
▁medical 2.806640625
▁mar 0.0205078125
iju 0.005290985107421875
ana 3.325939178466797e-05
, 0.1375732421875
▁and 0.07244873046875
▁mixed 6.078125
▁OP 8.8671875
MM 5.75
▁groups 0.5048828125
▁number 8.0859375
ed 0.00984954833984375
▁ 0.1365966796875
5 2.39453125
7 2.458984375
. 0.4404296875
1 2.375
%, 0.25732421875
▁ 0.005611419677734375
2 2.994140625
2 2.4765625
. 0.0987548828125
3 2.234375
%, 0.11083984375
▁and 0.0311279296875
▁ 0.002590179443359375
5 3.2890625
1 2.5
. 0.173828125
4 2.169921875
%, 0.406494140625
▁respectively 0.0090179443359375
. 0.42822265625
▁The 1.4794921875
▁pl 5.13671875
ur 0.0227508544921875
ality 3.5643577575683594e-05
▁of 0.05841064453125
▁anx 0.92919921875
iety 0.00859832763671875
▁contained 11.0546875
▁ 0.496826171875
4 1.66796875
8 2.443359375
. 0.07080078125
4 2.30859375
% 0.54052734375
▁among 1.48046875
▁OP 6.33203125
▁patients 9.09375
, 0.255615234375
▁ 0.09918212890625
2 1.42578125
1 2.404296875
. 0.13525390625
5 2.359375
% 0.010894775390625
▁among 0.426025390625
▁MM 0.3095703125
▁patients 0.247802734375
, 0.01338958740234375
▁and 0.01436614990234375
▁ 0.0360107421875
3 1.259765625
8 2.68359375
. 0.169677734375
7 2.283203125
% 0.01220703125
▁among 0.2296142578125
▁OP 4.109375
MM 0.191650390625
▁participants 3.611328125
. 0.33837890625
▁Pat 6.03515625
ients 0.0233001708984375
▁who 2.388671875
▁took 3.10546875
▁strong 8.015625
▁op 1.552734375
i 1.287109375
ates 0.0035247802734375
▁were 1.8681640625
▁t 9.109375
ended 1.2783203125
▁to 0.0153350830078125
▁place 10.5390625
▁their 3.666015625
▁pain 2.94921875
▁on 3.736328125
▁a 0.95458984375
▁scale 2.748046875
▁of 0.6259765625
▁ 0.343505859375
9 2.66796875
▁to 1.4248046875
▁ 0.0141448974609375
1 0.0305633544921875
0 0.07275390625
▁( 2.37890625
Fe 1.0908203125
ing 0.004344940185546875
old 0.00047397613525390625
▁et 0.006084442138671875
▁al 0.00042700767517089844
., 0.003753662109375
▁ 0.0009541511535644531
2 0.0002282857894897461
0 9.298324584960938e-06
1 0.0005669593811035156
7 0.004993438720703125
). 0.0377197265625
▁They 4.3671875
▁were 1.3134765625
▁also 1.3671875
▁an 8.90625
gu 5.08984375
ished 0.0277557373046875
▁em 8.59375
otion 0.0091094970703125
ally 0.002689361572265625
▁and 1.1025390625
▁react 6.76171875
ed 0.048828125
▁rad 9.3984375
ically 0.0025539398193359375
▁neg 5.26953125
atively 0.0008707046508789062
▁to 0.3359375
▁almost 5.13671875
▁all 1.2041015625
▁survey 6.92578125
▁questions 0.62109375
. 0.3056640625
▁Pat 4.33203125
ients 0.0074615478515625
▁who 1.1904296875
▁took 1.5478515625
▁only 5.296875
▁MM 0.791015625
▁or 3.19921875
▁mixed 3.984375
▁medic 2.580078125
ations 0.335205078125
▁course 12.8515625
▁had 2.390625
▁a 1.2958984375
▁significantly 2.62109375
▁more 3.96484375
▁stable 3.408203125
▁emot 1.166015625
ional 0.00839996337890625
▁state 0.92431640625
▁and 1.412109375
▁cop 5.52734375
ed 0.9921875
▁with 0.75927734375
▁pain 1.3125
▁more 1.7607421875
▁manage 7.0234375
able 2.408203125
. 0.52490234375
